A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
Xu, Shili, Catapang, Arthur, Braas, Daniel, Stiles, Linsey, Doh, Hanna M, Lee, Jason T, Graeber, Thomas G, Damoiseaux, Robert, Shirihai, Orian, Herschman, Harvey R
Published in Cancer & metabolism (28.06.2018)
Published in Cancer & metabolism (28.06.2018)
Get full text
Journal Article
Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin
Xu, Shili, Catapang, Arthur, Doh, Hanna M, Bayley, Nicholas A, Lee, Jason T, Braas, Daniel, Graeber, Thomas G, Herschman, Harvey R
Published in The Journal of nuclear medicine (1978) (01.02.2019)
Published in The Journal of nuclear medicine (1978) (01.02.2019)
Get full text
Journal Article
Hexokinase 2 Is Targetable for HK1-Negative, HK2-Positive Tumors from a Wide Variety of Tissues of Origin
Xu, Shili, Catapang, Arthur, Doh, Hanna M., Bayley, Nicholas A., Lee, Jason T., Braas, Daniel, Graeber, Thomas G., Herschman, Harvey R.
Published in Journal of Nuclear Medicine (01.02.2019)
Published in Journal of Nuclear Medicine (01.02.2019)
Get full text
Journal Article
Fine-tuning of Epithelial EGFR signals Supports Coordinated Mammary Gland Development
Samocha, Alexandr, Doh, Hanna M, Sitarama, Vaishnavi, Nguyen, Quy H, Gbenedio, Oghenekevwe, Rudolf, Joshua D, Eckalbar, Walter L, Barczak, Andrea J, Miao, Yi, Garcia, K Christopher, Lawson, Devon, Werb, Zena, Kessenbrock, Kai, Depeille, Philippe, Roose, Jeroen P
Published in bioRxiv (10.09.2020)
Published in bioRxiv (10.09.2020)
Get full text
Paper